frequency tx | C2I Accelerator

top of page

Frequency Therapeutics Closes $62MM Series C Financing

Frequency Therapeutics Closes $62MM Series C Financing

Congratulations to Frequency Therapeutics! They have announced the close of their $62mm Series C financing to expand research of their...

Featured Posts

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

CreaGen attends ACS Fall 2018 National Meeting!

CreaGen attends ACS Fall 2018 National Meeting!

C2I hosts exciting private summer social!

C2I hosts exciting private summer social!

CreaGen Life Science Incubator (C2I) is expanding!

CreaGen Life Science Incubator (C2I) is expanding!

6th Annual Advances in Chemical Sciences Symposium

6th Annual Advances in Chemical Sciences Symposium

Recent Posts

We are excited to welcome our new member, Analog Devices!

Welcome to our member, 100X Bioassay!

We are extending a warm welcome to our new member, Fieldstone Bio, Inc.!

C2I Accelerator 2023 Summer Mixer

Bioactivity Supports Premature Infants’ Immunity, Development, and Growth, According to a Review

ODDITY Invests $100M to Bring Revela's AI-Based Molecule Discovery Technology to Beauty and Wellness

Thank you for attending our panel discussion, Strategies to Advance Startups in Today's Environment!

Save the Date: Strategies to Advance Startups in Today's Environment

Welcome AlpaLifeB INC!

NESACS VIRTUAL October Meeting Features Dr. Murat Cirit, CEO & Co-Founder of Javelin Biotech!

Archive

bottom of page